Abstract

PIH36 - Cost-Effectiveness of Palivizumab Use in High Risk Children From Brazilian Health System Perspective

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Respiratory Syncytial Virus Prophylaxis
Asuncion MejíAs ... Pablo J SáNchez
NeoReviews | VOL. 6
Asuncion MejíAs, et. al.Asuncion MejíAs ... Pablo J SáNchez
01 Jan 2004
Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia.
Fahad Al Aql ... Saleh Al-Alaiyan
International Journal of Pediatrics and Adolescent Medicine | VOL. 3
Fahad Al Aql, et. al.Fahad Al Aql ... Saleh Al-Alaiyan
01 Jan 2015
Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands
Mark Nuijten ... Wolfgang Wittenberg
Journal of Medical Economics | VOL. 12
Mark Nuijten, et. al.Mark Nuijten ... Wolfgang Wittenberg
08 Oct 2009
Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections
-
PEDIATRICS | VOL. 112
--
01 Dec 2003
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers